ADVFN Logo
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

PTN Palatin Technologies Inc New

1.72
-0.01 (-0.58%)
Apr 25 2024 - Closed
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
Palatin Technologies Inc New PTN AMEX Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.01 -0.58% 1.72 20:00:00
Open Price Low Price High Price Close Price Prev Close
1.72 1.66 1.74 1.72 1.73
more quote information »

Recent News

Date Time Source Heading
4/25/20248:52IHNWFeaturedCannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA
4/08/202407:30PRNUSPalatin Announces Phase 3 PL9643 MELODY-1 Dry Eye Disease..
3/07/202417:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/04/202412:57EDGAR2Form 144 - Report of proposed sale of securities
2/28/202407:30PRNUSPalatin Announces Results of PL9643 MELODY-1 Pivotal Phase 3..
2/15/202409:00EDGAR2Form 8-K - Current report
2/15/202407:30PRNUSPalatin Reports Second Quarter Fiscal Year 2024 Financial..
2/14/202416:17EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2/14/202414:55EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2/09/202407:30PRNUSPalatin to Report Second Quarter Fiscal Year 2024 Results;..
2/05/202407:30PRNUSPalatin Announces Database Lock for PL9643 MELODY-1 Pivotal..
2/01/202417:16EDGAR2Form 8-K - Current report
2/01/202416:00PRNUSPalatin Announces Closing of $10 Million Registered Direct..
1/30/202408:00PRNUSPalatin Announces $10 Million Registered Direct Offering
1/08/202410:33PRNUSPalatin Provides Corporate Update and Highlights Strategic..
1/03/202408:00BWCosette Pharmaceuticals Acquires Vyleesi® (Bremelanotide..
12/20/202309:00EDGAR2Form 8-K - Current report
12/20/202307:30PRNUSPalatin Completes Sale of Vyleesi® to Cosette..
12/18/202316:45EDGAR2Form 8-K - Current report
12/18/202316:15PRNUSPalatin Receives Notice of Acceptance of the Listing..
12/18/202300:15EDGAR2Form EFFECT - Notice of Effectiveness
12/08/202317:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/06/202317:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/06/202314:25EDGAR2Form 144 - Report of proposed sale of securities
12/04/202317:00EDGAR2Form S-1 - General form for registration of securities under..
12/01/202315:52EDGAR2Form 144 - Report of proposed sale of securities
11/14/202307:30PRNUSPalatin Reports First Quarter Fiscal Year 2024 Financial..
11/09/202307:30PRNUSPalatin to Report First Quarter Fiscal Year 2024 Results;..
10/24/202316:50PRNUSPalatin Announces Closing of $5 Million Registered Direct..
10/24/202316:05EDGAR2Form 8-K - Current report
10/23/202307:30PRNUSPalatin Announces $5 Million Registered Direct Offering
10/19/202308:01EDGAR2Form 8-K - Current report
10/19/202307:30PRNUSPalatin Announces Preliminary Quarter Ended September 30,..
10/18/202307:30PRNUSPalatin Announces Positive Preclinical Data Showing..
10/16/202307:30PRNUSPalatin Presents Data at the United European..
10/13/202316:31EDGAR2Form 8-K - Current report
10/13/202316:15PRNUSPalatin Receives Notice of Non-Compliance from NYSE American
9/28/202308:02EDGAR2Form 8-K - Current report
9/28/202308:00EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
9/28/202307:30PRNUSPalatin Reports Fourth Quarter and Fiscal Year Ended 2023..
9/22/202316:00PRNUSPalatin to Report Fourth Quarter and Fiscal Year End 2023..
9/08/202308:00EDGAR2Form 8-K - Current report
9/07/202316:00PRNUSPalatin to Present at the H.C. Wainwright 25th Annual Global..
9/07/202308:49EDGAR2Form 8-K - Current report
9/07/202307:30PRNUSPalatin Completes Enrollment in Phase 3 MELODY-1 Study of..
8/16/202321:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/16/202321:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/10/202308:15EDGAR2Form 8-K - Current report
8/10/202307:30PRNUSPalatin Initiates Clinical Program for Bremelanotide..
8/08/202308:00EDGAR2Form 8-K - Current report
8/08/202307:30PRNUSPalatin's Vyleesi® Licensee Fosun Pharma Reports First..

Your Recent History

Delayed Upgrade Clock